These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 27661103)

  • 41. Epigenetic silencing of miR-490-3p promotes development of an aggressive colorectal cancer phenotype through activation of the Wnt/β-catenin signaling pathway.
    Zheng K; Zhou X; Yu J; Li Q; Wang H; Li M; Shao Z; Zhang F; Luo Y; Shen Z; Chen F; Shi F; Cui C; Zhao D; Lin Z; Zheng W; Zou Z; Huang Z; Zhao L
    Cancer Lett; 2016 Jun; 376(1):178-87. PubMed ID: 27037061
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Large-scale N-terminal deletions but not point mutations stabilize beta-catenin in small bowel carcinomas, suggesting divergent molecular pathways of small and large intestinal carcinogenesis.
    Breuhahn K; Singh S; Schirmacher P; Bläker H
    J Pathol; 2008 Jul; 215(3):300-7. PubMed ID: 18491352
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A protein knockdown strategy to study the function of beta-catenin in tumorigenesis.
    Cong F; Zhang J; Pao W; Zhou P; Varmus H
    BMC Mol Biol; 2003 Sep; 4():10. PubMed ID: 14516475
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Maintenance of adenomatous polyposis coli (APC)-mutant colorectal cancer is dependent on Wnt/beta-catenin signaling.
    Scholer-Dahirel A; Schlabach MR; Loo A; Bagdasarian L; Meyer R; Guo R; Woolfenden S; Yu KK; Markovits J; Killary K; Sonkin D; Yao YM; Warmuth M; Sellers WR; Schlegel R; Stegmeier F; Mosher RE; McLaughlin ME
    Proc Natl Acad Sci U S A; 2011 Oct; 108(41):17135-40. PubMed ID: 21949247
    [TBL] [Abstract][Full Text] [Related]  

  • 45. An immunohistochemical approach to detect oncogenic CTNNB1 mutations in primary neoplastic tissues.
    Akyol A; Güner G; Özşeker HS; Işık A; Atcı Ö; Uzun S; Atayar E; Ozaltin F; Gedikoğlu G; Sökmensüer C; Fearon ER
    Lab Invest; 2019 Jan; 99(1):128-137. PubMed ID: 30177831
    [TBL] [Abstract][Full Text] [Related]  

  • 46. An investigation of WNT pathway activation and association with survival in central nervous system primitive neuroectodermal tumours (CNS PNET).
    Rogers HA; Miller S; Lowe J; Brundler MA; Coyle B; Grundy RG
    Br J Cancer; 2009 Apr; 100(8):1292-302. PubMed ID: 19293793
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Somatic mutations of adenomatous polyposis coli gene and nuclear b-catenin accumulation have prognostic significance in invasive urothelial carcinomas: evidence for Wnt pathway implication.
    Kastritis E; Murray S; Kyriakou F; Horti M; Tamvakis N; Kavantzas N; Patsouris ES; Noni A; Legaki S; Dimopoulos MA; Bamias A
    Int J Cancer; 2009 Jan; 124(1):103-8. PubMed ID: 18844223
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The gain-of-function mutation E76K in SHP2 promotes CAC tumorigenesis and induces EMT via the Wnt/β-catenin signaling pathway.
    Zhang Q; Li Y; Zhao R; Wang X; Fan C; Xu Y; Liu Y; Li J; Wang S
    Mol Carcinog; 2018 May; 57(5):619-628. PubMed ID: 29323748
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The majority of β-catenin mutations in colorectal cancer is homozygous.
    Arnold A; Tronser M; Sers C; Ahadova A; Endris V; Mamlouk S; Horst D; Möbs M; Bischoff P; Kloor M; Bläker H
    BMC Cancer; 2020 Oct; 20(1):1038. PubMed ID: 33115416
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Wnt-driven LARGE2 mediates laminin-adhesive O-glycosylation in human colonic epithelial cells and colorectal cancer.
    Dietinger V; García de Durango CR; Wiechmann S; Boos SL; Michl M; Neumann J; Hermeking H; Kuster B; Jung P
    Cell Commun Signal; 2020 Jun; 18(1):102. PubMed ID: 32586342
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The Notch-2 gene is regulated by Wnt signaling in cultured colorectal cancer cells.
    Ungerbäck J; Elander N; Grünberg J; Sigvardsson M; Söderkvist P
    PLoS One; 2011 Mar; 6(3):e17957. PubMed ID: 21437251
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Wnt/beta-catenin pathway deregulation in childhood adrenocortical tumors.
    Leal LF; Mermejo LM; Ramalho LZ; Martinelli CE; Yunes JA; Seidinger AL; Mastellaro MJ; Cardinalli IA; Brandalise SR; Moreira AC; Tone LG; Scrideli CA; Castro M; Antonini SR
    J Clin Endocrinol Metab; 2011 Oct; 96(10):3106-14. PubMed ID: 21849527
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The metastasis suppressor, NDRG1, inhibits "stemness" of colorectal cancer via down-regulation of nuclear β-catenin and CD44.
    Wangpu X; Yang X; Zhao J; Lu J; Guan S; Lu J; Kovacevic Z; Liu W; Mi L; Jin R; Sun J; Yue F; Ma J; Lu A; Richardson DR; Wang L; Zheng M
    Oncotarget; 2015 Oct; 6(32):33893-911. PubMed ID: 26418878
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Wnt/FZD signaling and colorectal cancer morphogenesis.
    Hlubek F; Spaderna S; Schmalhofer O; Jung A; Kirchner T; Brabletz T
    Front Biosci; 2007 Jan; 12():458-70. PubMed ID: 17127310
    [TBL] [Abstract][Full Text] [Related]  

  • 55. In Colorectal Cancer Cells With Mutant KRAS, SLC25A22-Mediated Glutaminolysis Reduces DNA Demethylation to Increase WNT Signaling, Stemness, and Drug Resistance.
    Wong CC; Xu J; Bian X; Wu JL; Kang W; Qian Y; Li W; Chen H; Gou H; Liu D; Yat Luk ST; Zhou Q; Ji F; Chan LS; Shirasawa S; Sung JJ; Yu J
    Gastroenterology; 2020 Dec; 159(6):2163-2180.e6. PubMed ID: 32814111
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Therapeutic potential of targeting the Wnt/β-catenin signaling pathway in colorectal cancer.
    Cheng X; Xu X; Chen D; Zhao F; Wang W
    Biomed Pharmacother; 2019 Feb; 110():473-481. PubMed ID: 30530050
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Mutational Mechanisms That Activate Wnt Signaling and Predict Outcomes in Colorectal Cancer Patients.
    Hankey W; McIlhatton MA; Ebede K; Kennedy B; Hancioglu B; Zhang J; Brock GN; Huang K; Groden J
    Cancer Res; 2018 Feb; 78(3):617-630. PubMed ID: 29212857
    [No Abstract]   [Full Text] [Related]  

  • 58. Analysis of molecular aberrations of Wnt pathway gladiators in colorectal cancer in the Kashmiri population.
    Syed Sameer A; Shah ZA; Abdullah S; Chowdri NA; Siddiqi MA
    Hum Genomics; 2011 Jul; 5(5):441-52. PubMed ID: 21807601
    [TBL] [Abstract][Full Text] [Related]  

  • 59. CPT2 downregulation triggers stemness and oxaliplatin resistance in colorectal cancer via activating the ROS/Wnt/β-catenin-induced glycolytic metabolism.
    Li H; Chen J; Liu J; Lai Y; Huang S; Zheng L; Fan N
    Exp Cell Res; 2021 Dec; 409(1):112892. PubMed ID: 34688609
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Twa1/Gid8 is a β-catenin nuclear retention factor in Wnt signaling and colorectal tumorigenesis.
    Lu Y; Xie S; Zhang W; Zhang C; Gao C; Sun Q; Cai Y; Xu Z; Xiao M; Xu Y; Huang X; Wu X; Liu W; Wang F; Kang Y; Zhou T
    Cell Res; 2017 Dec; 27(12):1422-1440. PubMed ID: 28829046
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.